share_log

SenesTech | 8-K: Current report

SenesTech | 8-K: Current report

SenesTech | 8-K：重大事件
美股SEC公告 ·  08/05 16:09

Moomoo AI 已提取核心信息

SenesTech, Inc., a company listed on The Nasdaq Stock Market, announced that it has received a notification from Nasdaq on July 31, 2024, regarding non-compliance with the exchange's audit committee requirements following the departure of Delphine François Chiavarini from the Board and Audit Committee effective July 11, 2024. The Nasdaq Listing Rule 5605 mandates that the Audit Committee must have at least three independent directors. SenesTech has been granted a cure period to regain compliance, which lasts until the earlier of their next annual stockholders' meeting or July 11, 2025, or by January 7, 2025, if the next annual meeting occurs before that date. The company is actively seeking a qualified independent board member to fulfill the audit committee criteria and reestablish compliance within the given timeframe. The notification from Nasdaq does not immediately affect the listing of SenesTech's common stock, and the company intends to use the cure period to address the issue. However, SenesTech acknowledges that there is no guarantee of regaining or maintaining compliance with Nasdaq's continued listing requirements.
SenesTech, Inc., a company listed on The Nasdaq Stock Market, announced that it has received a notification from Nasdaq on July 31, 2024, regarding non-compliance with the exchange's audit committee requirements following the departure of Delphine François Chiavarini from the Board and Audit Committee effective July 11, 2024. The Nasdaq Listing Rule 5605 mandates that the Audit Committee must have at least three independent directors. SenesTech has been granted a cure period to regain compliance, which lasts until the earlier of their next annual stockholders' meeting or July 11, 2025, or by January 7, 2025, if the next annual meeting occurs before that date. The company is actively seeking a qualified independent board member to fulfill the audit committee criteria and reestablish compliance within the given timeframe. The notification from Nasdaq does not immediately affect the listing of SenesTech's common stock, and the company intends to use the cure period to address the issue. However, SenesTech acknowledges that there is no guarantee of regaining or maintaining compliance with Nasdaq's continued listing requirements.
SenesTech公司是一家在纳斯达克股票交易所上市的公司。该公司于2024年7月31日收到了纳斯达克的通知，称其在董事会和审计委员会成员Delphine François Chiavarini离职后没有遵守交易所的审计委员会要求的规定。纳斯达克上市规则5605规定，审计委员会必须至少有三名独立董事。SenesTech公司获得了治愈期来恢复合规性，该期限延续至下次年度股东大会之前或2025年7月11日之前的任何日期，或者如果下次年度大会在此日期之前举行，则到2025年1月7日为止。该公司正在积极寻求一位合格的独立董事来满足审计委员会的条件并在规定的时间内重新确立合规性。纳斯达克的通知不会立即影响SenesTech普通股的上市，该公司打算利用治愈期解决这个问题。然而，SenesTech公司承认，无法保证恢复或维护纳斯达克的继续上市要求的合规性。
SenesTech公司是一家在纳斯达克股票交易所上市的公司。该公司于2024年7月31日收到了纳斯达克的通知，称其在董事会和审计委员会成员Delphine François Chiavarini离职后没有遵守交易所的审计委员会要求的规定。纳斯达克上市规则5605规定，审计委员会必须至少有三名独立董事。SenesTech公司获得了治愈期来恢复合规性，该期限延续至下次年度股东大会之前或2025年7月11日之前的任何日期，或者如果下次年度大会在此日期之前举行，则到2025年1月7日为止。该公司正在积极寻求一位合格的独立董事来满足审计委员会的条件并在规定的时间内重新确立合规性。纳斯达克的通知不会立即影响SenesTech普通股的上市，该公司打算利用治愈期解决这个问题。然而，SenesTech公司承认，无法保证恢复或维护纳斯达克的继续上市要求的合规性。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间